SCHEMBL8869360

SCHEMBL8869360

CC(=O)NCCc1ccc(S(=O)(=O)NC(=O)c2ccc(C(=O)NCC(=O)O)nc2)cc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
P4HTM Q9NXG6 5/20 0.50
POLB P06746 1/20 0.46
MEN1 O00255 1/20 0.46
KMT2A Q03164 1/20 0.46
SMN1; SMN2 Q16637 2/20 0.45
LMNA P02545 2/20 0.45
CYP3A4 P08684 1/20 0.45
HTR1A P08908 1/20 0.45
MAPT P10636 1/20 0.45
CYP2C9 P11712 1/20 0.45
TSHR P16473 1/20 0.45
NFKB1 P19838 1/20 0.45
CNR1 P21554 1/20 0.45
CYP2C19 P33261 1/20 0.45
ADRA1A P35348 1/20 0.45
BLM P54132 1/20 0.45
EGFR P00533 2/20 0.45
EGLN1 Q9GZT9 2/20 0.42
NPC1 O15118 1/20 0.42
RAB9A P51151 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8868528 0.90 P4HTM (0.50) P4HTMPOLBMEN1KMT2ASMN1; SMN2
SCHEMBL8869478 0.90 P4HTM (0.49) P4HTMPOLBMEN1KMT2ASMN1; SMN2
SCHEMBL9139086 0.90 P4HTM (0.63) P4HTMPOLBMEN1KMT2ASMN1; SMN2
SCHEMBL8868411 0.89 P4HTM (0.55) P4HTMMEN1KMT2ASMN1; SMN2LMNA
SCHEMBL8869113 0.88 EGFR (0.54) P4HTMSMN1; SMN2MAPTCYP2C19EGFR
SCHEMBL8868287 0.88 P4HTM (0.56) P4HTMMEN1KMT2ASMN1; SMN2MAPT
SCHEMBL8867801 0.87 MAPT (0.52) P4HTMMEN1KMT2ASMN1; SMN2LMNA
SCHEMBL8869375 0.87 P4HTM (0.51) P4HTMPOLBMEN1KMT2ASMN1; SMN2
SCHEMBL8869989 0.87 P4HTM (0.59) P4HTMMEN1KMT2ALMNAMAPT
SCHEMBL8868346 0.87 P4HTM (0.45) P4HTMPOLBMEN1KMT2ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5607954-A Sulfonamido- and sulfonamidocarbonylpyridine-2-carboxamides and their pyridine-n-oxides, process for their preparation and their use as pharmaceuticals HOECHST AKTIENGESELLSCHAFT (DE) 1997-03-04 US disclosed